Program Description: 

This educational activity is designed to highlight innovation, discovery, or updates in medical science with an emphasis on how these apply to diagnosis, treatment, or outcomes in clinical care of the pediatric patient. It also disseminates current changes in health care policies and trends in health care education and professionalism. Education is provided by speakers that present basic science in such a way that is educational and relevant to a general clinician.  Speakers provide updates on clinical guidelines for diagnosis and treatment using evidence-based medicine from the literature and leading experts. On topics of health care policies, epidemiologic changes and population health, or health care education or professionalism, specific speakers are sought for their expertise and present in these areas.  Invited speakers from other academic institutions, as well as internal MCW faculty, form the PGR speaker roster.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 
  • Physicians                       
  • Physician (fellows/residents)        
  • Physician Assistants 
  • Nurse Practitioners
  • Nurses                   
  • AP/NP
  • Pharmacists
  • Psychologist
  • Social Workers
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Identify the causes of and current outcomes for children with intestinal failure
  • Describe the mechanism of adaptation for children with intestinal failure
  • Discuss the role of injectable lipid emulsions (ILEs) in the development of intestinal failure associated liver disease (IFALD) and how alterations in the type of ILEs may prevent IFALD
  • Review the role of GLP-2 agonists in promoting adaptation 


.

Faculty & credentials: 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Presenter: 

Catherine Larson-Nath MD, CNSC
Pediatric Gastroenterology, Hepatology, and Nutrition
Director of Intestinal Rehabilitation Program
Director, Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship
University of Minnesota

 

 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

NameCompanyRole
   
   

 

Contact

Name: 
Stephanie Dhein
Phone number: 
+1 (414) 337-7030
Session date: 
Friday, August 27, 2021 - 8:30am to 9:30am
Location: 
Children's Wisconsin
8915 W. Connell Ct.
Zoom Conference
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.